SEC Expands Pfizer Bribery Inquiries Into China

By Al Barbarino · November 6, 2020, 5:37 PM EST

Pfizer Inc. is cooperating with the U.S. Securities and Exchange Commission following a bribery-related inquiry into the drugmaking giant's China operations, according to the company's third-quarter financial statements....

To view the full article, register now.